HCA Healthcare (NYSE:HCA) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $9.80-10.40 for the period, compared to the Thomson Reuters consensus estimate of $10.03. The company issued revenue guidance of $50.5-51.5 billion, compared to the consensus revenue estimate of $50.77 billion.
A number of research analysts recently commented on the stock. SunTrust Banks raised their price objective on shares of HCA Healthcare to $175.00 and gave the company a buy rating in a research note on Wednesday, January 30th. Zacks Investment Research upgraded shares of HCA Healthcare from a hold rating to a buy rating and set a $139.00 price objective on the stock in a research note on Friday, May 3rd. Jefferies Financial Group set a $158.00 price objective on shares of HCA Healthcare and gave the company a buy rating in a research note on Wednesday, April 17th. UBS Group raised their price objective on shares of HCA Healthcare from $164.00 to $172.00 and gave the company a buy rating in a research note on Wednesday, May 1st. Finally, Leerink Swann raised their price objective on shares of HCA Healthcare from $160.00 to $175.00 and gave the company an outperform rating in a research note on Wednesday, January 30th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and nineteen have given a buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $149.41.
HCA Healthcare stock traded up $0.06 during midday trading on Wednesday, reaching $128.21. The stock had a trading volume of 1,012,800 shares, compared to its average volume of 1,801,879. HCA Healthcare has a twelve month low of $101.30 and a twelve month high of $147.42. The firm has a market capitalization of $43.75 billion, a price-to-earnings ratio of 13.12, a P/E/G ratio of 0.99 and a beta of 0.75.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $2.97 EPS for the quarter, topping analysts’ consensus estimates of $2.31 by $0.66. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. The firm had revenue of $12.52 billion during the quarter, compared to analyst estimates of $12.34 billion. During the same quarter last year, the business posted $3.18 EPS. The company’s revenue was up 9.6% on a year-over-year basis. Equities analysts expect that HCA Healthcare will post 10.38 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Monday, June 3rd will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend is Friday, May 31st. HCA Healthcare’s dividend payout ratio is 16.38%.
In related news, insider Jon M. Foster sold 44,281 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the transaction, the insider now owns 96,052 shares of the company’s stock, valued at approximately $11,745,238.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.70% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “HCA Healthcare (NYSE:HCA) Updates FY19 Earnings Guidance” was first posted by Sundance Herald and is the property of of Sundance Herald. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://sundanceherald.com/2019/05/22/hca-healthcare-hca-updates-fy19-earnings-guidance.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
See Also: FAANG Stocks
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.